摘要
目的:探讨欣母沛在治疗子宫收缩乏力性产后出血的临床疗效。方法:选择2011年12月-2012年6月在笔者所在医院收治的产后出血产妇共96例,随机分为缩宫素组(先宫底注射缩宫素20U,再采用5%葡萄糖液500ml加缩宫素20U静脉滴注治疗)与欣母沛组(注射、静滴缩宫素并联合应用欣母沛治疗)各48例,观察两组产妇产后2h与24h出血量、子宫收缩情况及用药后的不良反应。结果:欣母沛组产后2h与24h出血量分别为(191.43±56.53)ml、(296.69±55.91)ml,与缩宫素组(323.65±68.77)ml、(402.82±67.88)ml比较差异有统计学意义(P<0.05);欣母沛组子宫收缩总有效率为93.75%,与缩宫素组子宫收缩总有效率81.25%比较差异有统计学意义(P<0.05)。两组产妇在用药后不反应分别为6.3%和8.3%,比较差异无统计学意义(P>0.05)。结论:欣母沛在治疗缩乏力性产后出血有显著的疗效,是简单、安全的有效方法,值得临床广泛使用.
Objective：To investigate the hemabate in treatment of uterine contraction asthenia postpartum hemorrhage.Method：From 2011 December to 2012 June,choose 96 cases of postpartum hemorrhage in our hospital,randomized to oxytocin group（using a 5% glucose solution 500 ml and oxytocin 20 U intravenously） with hemabate group（intravenous drip of oxytocin and combined application of hemabate on） 48 cases were observed in the two groups,2 h and 24 h in maternal postpartum bleeding,uterine contraction and after drug adverse reaction.Result：Hemabate group of postpartum 2 h and 24 h output respectively（191.43±56.53） ml,（296.69±55.91） ml,and oxytocin group（323.65±68.77） ml,（402.82±67.88） ml compared the difference was statistically significant（P0.05）;uterine contraction of hemabate group total rate of 93.75% and oxytocin group contraction of the uterus the total efficiency of 81.25%,compared the difference was statistically significant（P0.05）.Two groups of women after treatment response were 6.3% and 8.3%：the differences were not statistically significant（P0.05）.Conclusion：Hemabate in treatment of postpartum hemorrhage of uterine atony shrinkage has significant curative effect,is simple,safe and effective method,is worth the clinical widely used.
出处
《中国医学创新》
CAS
2012年第36期22-23,共2页
Medical Innovation of China
关键词
产后出血
欣母沛
出血量
Postpartum hemorrhage
Hemabate
Amount of blood loss
